7-41720402-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000415848.6(INHBA-AS1):​n.358+9620A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.762 in 152,212 control chromosomes in the GnomAD database, including 44,638 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.76 ( 44638 hom., cov: 33)

Consequence

INHBA-AS1
ENST00000415848.6 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0230

Publications

2 publications found
Variant links:
Genes affected
INHBA-AS1 (HGNC:40303): (INHBA antisense RNA 1)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000415848.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.796 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000415848.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INHBA-AS1
NR_027118.2
n.355+9620A>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INHBA-AS1
ENST00000415848.6
TSL:1
n.358+9620A>G
intron
N/A
INHBA-AS1
ENST00000662248.1
n.280+9620A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.763
AC:
115979
AN:
152094
Hom.:
44612
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.720
Gnomad AMI
AF:
0.910
Gnomad AMR
AF:
0.631
Gnomad ASJ
AF:
0.752
Gnomad EAS
AF:
0.753
Gnomad SAS
AF:
0.738
Gnomad FIN
AF:
0.882
Gnomad MID
AF:
0.715
Gnomad NFE
AF:
0.801
Gnomad OTH
AF:
0.735
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.762
AC:
116052
AN:
152212
Hom.:
44638
Cov.:
33
AF XY:
0.764
AC XY:
56904
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.720
AC:
29897
AN:
41506
American (AMR)
AF:
0.630
AC:
9636
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.752
AC:
2608
AN:
3470
East Asian (EAS)
AF:
0.752
AC:
3890
AN:
5170
South Asian (SAS)
AF:
0.737
AC:
3548
AN:
4814
European-Finnish (FIN)
AF:
0.882
AC:
9361
AN:
10616
Middle Eastern (MID)
AF:
0.704
AC:
207
AN:
294
European-Non Finnish (NFE)
AF:
0.801
AC:
54516
AN:
68020
Other (OTH)
AF:
0.737
AC:
1559
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1409
2819
4228
5638
7047
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
860
1720
2580
3440
4300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.774
Hom.:
18281
Bravo
AF:
0.736
Asia WGS
AF:
0.734
AC:
2552
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
4.4
DANN
Benign
0.44
PhyloP100
0.023

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs6463037;
hg19: chr7-41760000;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.